Post-market follow-up of the NEMOST V2 spinal implant
Official title: Post-market Clinical Follow-up Study of NEMOST V2 Growing Domino
Run by Euros · NCT07403084 · Data updated 2026-11-12
This project will try the NEMOST V2 growing domino in children aged 5–17 with progressive scoliosis to track safety and device performance over five years.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 17 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Euros Industry-sponsored |
| Locations | 5 sites (Nice, Provence-Alpes-Côte d'Azur Region and 4 other locations) |
| Status | Recruiting |
| Started | December 19, 2025 |
| Main results expected | December 19, 2033 |
| Study ends | December 19, 2033 |
| Registry record updated | February 11, 2026 |
| Trial ID | NCT07403084 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 5–17 with progressive idiopathic, congenital, neuromuscular, or syndromic scoliosis who require primary surgical intervention and whose parents or guardians consent.
✕Probably not a fit
Patients with local inflammation or active infection, pathological obesity, non-reducible scoliosis, allergy to implant materials, insufficient tissue coverage, or prior spinal instrumentation/fusion are unlikely to benefit from this implant.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, non-randomized post-market surveillance will collect retrospective and prospective clinical and radiological data on 140 children treated with the NEMOST V2 growing domino for progressive scoliosis. Participants aged 5–17 with idiopathic, congenital, neuromuscular, or syndromic scoliosis requiring primary surgical intervention will be enrolled at three French centers. The study is interventional but uncontrolled, and follows patients for five years after surgery to record complications (primary objective) and device performance (secondary objective). Clinical exams and imaging at scheduled postoperative intervals will be used to characterize safety events and the long-term behavior of the implant.
Why it matters
Potential benefit: If successful, the study could confirm that NEMOST V2 controls spinal curvature while allowing growth and has an acceptable safety profile, potentially reducing the need for additional procedures.
How similar studies have gone: Other growth-friendly spinal devices (growing rods, VEPTR, magnetically controlled rods) have shown mixed success with known complication profiles, while NEMOST-specific long-term data remain limited beyond its market release.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Idiopathic, congenital, neuromuscular, or syndromic scoliosis : Progressive spinal deformity not managed by orthopedic treatment, and requiring primary surgical intervention. * The patient, as well as their parents or legal guardians, are informed of the participation in the study. * Patients aged from 5 to 17 yeas old, excepted the one who still have a potential for growth Exclusion Criteria: * signs of local inflammation; * acute or chronic, local or systemic infections ; * non-reducible scoliosis ; * pathological obesity ; * allergy or intolerance to implanted materials; * insufficiency or absence of tissue coverage. The NEMOST implant should not be used in a spine that has already been instrumented or fused.
Where it's running
-
Hopital Lenval Nice
Nice, Provence-Alpes-Côte d'Azur Region, France Recruiting -
CHU Pellegrin
Bordeaux, France Recruiting -
Hospices Civils de Lyon
Lyon, France Not yet recruiting -
Hopital Armand Trousseau
Paris, France Not yet recruiting -
Hopital Necker
Paris, France Not yet recruiting
Study contacts
- Principal investigator: Federico Solla, MD — Centre Hospitalier Universitaire de Nice
- Study coordinator: Célia Armanet, PHD
- Email: carmanet@euros.fr
- Phone: +330756848896
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-resolution MRI of paravertebral (back) muscles in children with idiopathic or neuromuscular scoliosis
We will use a short, extra high-resolution MRI to see if differences in the deep back muscles are linked to scoliosis in children aged 10–17 with idiopathic or neuromuscular forms.
-
TXA in kids undergoing scoliosis surgery
This trial tests whether tranexamic acid can reduce blood loss and the need for transfusions in children aged 10–18 having surgery for idiopathic scoliosis.
-
Diffusion in the growing spine: ADC of the intervertebral disc in children
This study tests whether MRI diffusion measurements in the intervertebral disc can help understand differences between scoliotic and healthy children.
-
Preoperative IV iron for teens having spinal fusion to correct scoliosis
This trial will try giving a single IV iron infusion before spinal fusion to see if it helps 10–19-year-olds with scoliosis and low iron by reducing blood transfusions and improving recovery.
-
Breathing muscle training for children and teens with idiopathic scoliosis during Schroth therapy
This project will see if adding inspiratory muscle training to Schroth therapy helps 11–16-year-olds with idiopathic scoliosis breathe better, tolerate exercise more, and strengthen their core.
-
Schroth method with and without core stabilization exercises for adolescents with idiopathic scoliosis
This trial tests whether adding core stabilization exercises to the Schroth method helps teens (ages 10–18) with mild idiopathic scoliosis reduce spinal curve, build back endurance, increase chest mobility, and improve quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.